PMID: 26907557
Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 26907557
Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content:** The research question investigates whether the vascular-guided multilayer preauricular approach (VMPA) to the temporomandibular joint (TMJ) can enhance surgical access and reduce complications compared to existing methods.
- **Key Information to Look For:** Effectiveness of VMPA in providing better access, reduction in complications (such as nerve damage or severe postoperative issues), success rates of surgeries, and overall patient outcomes as reported in the study.

**2. Evidence Evaluation**
- **Research Results and Data:** The study included 606 TMJ surgeries performed using VMPA. All surgeries were successful with favorable incision healing. Importantly, no patients experienced permanent facial nerve weakness or severe complications. Additionally, the approach provided direct access and good visibility of the TMJ region, leading to favorable esthetic and functional results.
- **Strength and Reliability:** The study's large sample size (606 joints) and the absence of severe complications suggest robust positive outcomes. However, it is a retrospective study, which may have inherent biases and lacks the control of prospective or randomized studies.
- **Relevance to the Question:** The evidence directly addresses the question by demonstrating that VMPA can improve surgical access and minimize complications in TMJ surgeries, supporting its efficacy as a preferred surgical approach.

**3. Conclusion**
Based on the data presented, the VMPA shows promise in enhancing surgical access and reducing complications in TMJ surgeries. While the retrospective nature of the study limits the ability to establish causality definitively, the high success rate and absence of severe complications provide strong support for the efficacy of VMPA.

**4. Final Answer:**
**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether the vascular-guided multilayer preauricular approach (VMPA) improves access to the temporomandibular joint (TMJ) and reduces complications compared to other surgical approaches. Key information to evaluate includes the study's outcomes on surgical access, complication rates, and functional/aesthetic results.  

**2. Evidence Evaluation**  
- **Access and Visibility**: The abstract explicitly states that the VMPA "can provide direct access and favorable visibility to the TMJ region," addressing the first part of the question.  
- **Complications**: The study reports "no patient developed permanent weakness of the facial nerve or other severe complications," and all incisions healed well. Subjective complaints about scars were not mentioned as issues.  
- **Study Design**: The study is a retrospective evaluation of 606 joints in patients without prior TMJ surgery, with at least 6 months of follow-up. While it lacks a control group for direct comparison, the results are uniformly positive (100% surgical success, no severe complications).  
- **Strengths/Limitations**: The large sample size (606 joints) and absence of severe complications support the claim. However, the lack of a control group limits definitive comparison to other approaches, and the study’s reliance on retrospective data may introduce selection biases.  

**3. Conclusion**  
The evidence strongly supports that the VMPA improves access (via "direct access and favorable visibility") and reduces complications (no severe outcomes reported). While the study design has limitations (no control group), the results are consistent and unambiguous within the reported cohort. The abstract’s conclusion also endorses the VMPA as a preferred approach, aligning with the findings.  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether the vascular-guided multilayer preauricular approach (VMPA) improves surgical access to the temporomandibular joint (TMJ) and reduces complications. Key information to evaluate includes data on surgical access (e.g., visibility, direct access), complication rates (e.g., nerve damage, scarring), and outcomes compared to existing approaches.

**2. Evidence Evaluation**  
The abstract reports that 606 TMJ surgeries using VMPA were successful, with no permanent facial nerve weakness or severe complications. Incisions healed well, and the approach provided "direct access and favorable visibility." However, the study is retrospective, lacks a control group (e.g., comparing VMPA to traditional approaches), and does not quantify improvements in access (e.g., operative time reduction) or complication rates relative to alternatives. While the absence of permanent complications and favorable outcomes suggest reduced risks, the evidence strength is limited by the study design and absence of comparative data.

**3. Conclusion**  
The abstract supports that VMPA improves access and reduces complications based on direct clinical outcomes (successful surgeries, no permanent nerve damage). However, the lack of comparative data and reliance on a single retrospective study introduce uncertainty. A "maybe" is warranted due to insufficient evidence to conclusively confirm superiority over other methods.

**4. Final Answer**  
**My final choice is: maybe**
DeepSeek selected: maybe

-------- Debate round 1 --------

----------------------- GPT's response -----------------------
GPT is generating the response...


**1. Position Statement**

**I agree with Qwen's perspective** but maintain my original position of "yes" based on the evidence presented.

**2. Evaluation of Other Models**

- **Qwen's Perspective:** Qwen also concluded with a "yes," aligning with my assessment. Qwen acknowledged the large sample size and absence of severe complications, while also noting limitations such as the lack of a control group and potential selection biases inherent in a retrospective study. However, Qwen determined that the evidence strongly supports the effectiveness of VMPA in improving access and reducing complications.

- **DeepSeek's Perspective:** DeepSeek opted for a "maybe," primarily due to concerns about the study's retrospective nature and the absence of comparative data with other surgical approaches. While these are valid points regarding the strength of evidence, DeepSeek's conclusion may be overly cautious given the positive outcomes reported.

**3. Medical Analysis and Argumentation**

The abstract provides substantial evidence supporting the efficacy of the VMPA in TMJ surgeries:

- **Large Sample Size:** With 606 TMJ surgeries, the study offers a robust data set, enhancing the reliability of the outcomes reported.

- **Positive Outcomes:** The absence of permanent facial nerve weakness and severe complications is significant, indicating that VMPA is a safe approach. Favorable esthetic and functional results further strengthen the case for VMPA.

- **Direct Access and Visibility:** The ability to provide direct access and favorable visibility to the TMJ region is crucial for successful surgical interventions, potentially reducing operative time and improving precision.

While the study is retrospective and lacks a control group, the uniformity and positivity of the results across a large number of cases mitigate some concerns about study design limitations. Additionally, the abstract's conclusion supporting VMPA as the approach of choice for common TMJ surgeries suggests a consensus based on the experiences reported.

**4. Self-Questioning**

- **Has the rationale for my original choice truly been completely refuted?** No. While DeepSeek raises important points about study design limitations, the overwhelming positive outcomes and the endorsement of VMPA as the preferred approach in the abstract provide strong support for the "yes" conclusion.

- **Is the new choice better than my original choice?** No, maintaining "yes" remains the most supported choice given the evidence.

- **Explain why you persist with or change your choice:** I persist with the "yes" choice because the evidence presented sufficiently demonstrates that VMPA improves surgical access and reduces complications in TMJ surgeries, despite the inherent limitations of the study design.

**5. Final Decision**

**My final choice is: "yes"**
GPT selected: yes

----------------------- Qwen's response -----------------------
Qwen is generating the response...


**1. Position Statement**  
**I agree with GPT's viewpoint** and maintain my original position of "yes." While DeepSeek raises valid methodological concerns, the evidence directly supports that the VMPA improves access and reduces complications as per the question’s scope.  

**2. Evaluation of Other Models**  
- **GPT’s Analysis**: Correctly emphasizes the large sample size (606 joints) and absence of severe complications, aligning with the abstract’s conclusion. However, GPT could have more explicitly addressed the question’s focus on the **intrinsic merits of VMPA** (e.g., its access/visibility features) rather than solely comparing it to alternatives.  
- **DeepSeek’s Analysis**: Overemphasizes the need for comparative data to conclude superiority over other approaches. The question does not require a head-to-head comparison but asks whether VMPA itself improves access and reduces complications. The study’s results (e.g., "no permanent facial nerve weakness") directly address these points, making "maybe" overly cautious.  

**3. Medical Analysis and Argumentation**  
- **Key Evidence in the Abstract**:  
  - **Access/Visibility**: The VMPA explicitly provides "direct access and favorable visibility," which are critical for surgical precision and minimizing complications. This is a primary outcome supporting the question’s premise.  
  - **Complications**: No permanent facial nerve damage or severe complications were reported in 606 cases, strongly suggesting reduced risks. The absence of subjective scar complaints further supports low complication rates.  
  - **Functional/Aesthetic Results**: Favorable outcomes indicate that the approach achieves its goals without trade-offs, reinforcing its safety and efficacy.  

- **Study Design Context**:  
  - While a randomized controlled trial would strengthen evidence, the retrospective design does not negate the **demonstrated outcomes** of the VMPA itself. The question focuses on whether VMPA can achieve these improvements, not whether it is definitively superior to other methods.  
  - The absence of a control group does not invalidate the findings for the approach’s inherent benefits. For example, if a new surgical technique eliminates a known complication (e.g., facial nerve injury) in a large cohort, this is sufficient to answer "yes" to the question.  

**4. Self-Questioning**  
- **Has the rationale for my original choice been refuted?** No. The abstract’s data directly affirm improved access and reduced complications, even without a control group.  
- **Is the new choice better?** No. Maintaining "yes" is justified because the evidence answers the question as posed.  
- **Why persist?** The question is not about superiority over other approaches but whether VMPA itself achieves the stated outcomes. The abstract provides clear, unambiguous affirmative evidence for both improved access and reduced complications.  

**5. Final Decision**  
**My final choice is: "yes"**
Qwen selected: yes

----------------------- DeepSeek's response -----------------------
DeepSeek is generating the response...


**1. Position Statement**  
**I disagree with their viewpoints because:** While GPT and Qwen emphasize the positive outcomes reported in the abstract, they underestimate the critical limitations of the study design and misinterpret the question’s implicit requirement for comparative evidence to establish "improvement" over existing approaches.  

**2. Evaluation of Other Models**  
- **GPT/Qwen’s Overlooked Gaps**:  
  1. **Misinterpretation of "Improvement"**: The question asks whether VMPA *improves* access and *reduces* complications, which inherently requires comparison to historical or standard approaches. The abstract lacks such data, yet GPT/Qwen assume superiority based solely on favorable outcomes in a single-arm study.  
  2. **Retrospective Bias**: Neither model addresses the risk of selection bias in retrospective studies (e.g., surgeons selecting low-risk cases for VMPA), which could artificially inflate success rates.  
  3. **Temporary Complications**: The abstract reports "no permanent facial nerve weakness" but omits data on transient complications (e.g., temporary nerve paresis), which are critical for assessing safety.  
  4. **Quantitative Metrics**: GPT/Qwen accept "direct access and favorable visibility" as sufficient evidence of improved access, but the abstract provides no objective metrics (e.g., operative time, surgeon surveys, or comparison of visual field measurements) to validate these claims.  

**3. Medical Analysis and Argumentation**  
- **Key Unaddressed Issues**:  
  1. **Comparative Evidence**: The absence of a control group (e.g., traditional preauricular or endaural approaches) makes it impossible to conclude that VMPA *improves* access or *reduces* complications relative to alternatives. For example, if traditional approaches also report low complication rates in similar cohorts, VMPA’s benefits would be unproven.  
  2. **Outcome Specificity**: The abstract does not define "severe complications" or specify how complications were tracked (e.g., follow-up duration, assessment methods). Without standardized criteria, the reported outcomes lack reliability.  
  3. **Generalizability**: A single-center retrospective study risks institutional bias (e.g., surgeon expertise influencing outcomes more than the approach itself).  

- **Strength of Evidence**:  
  While the large sample size (606 surgeries) and absence of permanent complications are encouraging, these alone do not meet the threshold for concluding *improvement* over existing methods. In evidence-based medicine, comparative studies (e.g., RCTs or propensity-matched cohorts) are required to establish superiority.  

**4. Self-Questioning**  
- **Has the rationale for my original choice been refuted?** No. The other models’ arguments do not resolve the study’s methodological limitations or the lack of comparative data.  
- **Is the new choice better?** No. Maintaining "maybe" remains appropriate given the evidence’s incompleteness.  
- **Why persist?** The question hinges on *improvement* and *reduction*, which demand comparative evidence. The abstract’s data, while positive, do not conclusively address these comparative claims.  

**5. Final Decision**  
**My final choice is: "maybe"**
DeepSeek selected: maybe

-------- Debate round 2 --------

----------------------- GPT's response -----------------------
GPT is generating the response...


**1. Position Statement**

**I agree with Qwen's perspective** and maintain my original position of "yes" based on the evidence presented.

**2. Evaluation of Other Models**

- **Qwen's Perspective:** Qwen continues to support the "yes" position, aligning closely with my assessment. Qwen emphasizes the large sample size (606 TMJ surgeries) and the absence of severe complications, highlighting the direct access and favorable visibility provided by the VMPA. Qwen also points out that the question focuses on whether VMPA itself improves access and reduces complications, not necessarily its superiority over other methods, which supports the "yes" conclusion.

- **DeepSeek's Perspective:** DeepSeek maintains a "maybe" stance, reiterating concerns about the retrospective nature of the study and the lack of comparative data with other surgical approaches. DeepSeek underscores the importance of comparative evidence to substantiate claims of improvement and reduction in complications, suggesting that without such data, the conclusion may be premature.

**3. Medical Analysis and Argumentation**

The abstract under discussion provides compelling evidence in support of the VMPA for TMJ surgeries:

- **Large Sample Size and Robust Data:** Conducting 606 TMJ surgeries offers a substantial data set, enhancing the reliability and generalizability of the positive outcomes reported.

- **Safety Profile:** The absence of permanent facial nerve weakness and severe complications in such a large cohort is noteworthy. This highlights the VMPA's safety and minimizes concerns about significant adverse effects.

- **Direct Access and Enhanced Visibility:** VMPA's ability to provide direct access and favorable visibility to the TMJ region is crucial for surgical precision. This likely contributes to reduced operative time, improved surgical outcomes, and minimized trauma to surrounding tissues, thereby lowering the risk of complications.

- **Esthetic and Functional Outcomes:** Favorable esthetic results reduce patient morbidity related to scarring, while functional outcomes ensure the restoration of TMJ functionality, which are critical aspects of surgical success.

While DeepSeek raises valid points regarding the study's retrospective design and lack of comparative data, the consistency and positivity of the outcomes across a large number of cases provide strong indirect evidence supporting VMPA's effectiveness. Additionally, the endorsement of VMPA as the approach of choice in the abstract suggests that, in clinical practice, surgeons have found it to be superior based on practical experience, even if not formally compared in the study.

Furthermore, in surgical research, while randomized controlled trials (RCTs) are the gold standard, high-quality retrospective studies with large sample sizes can still offer valuable insights, especially in areas where RCTs may be challenging to conduct.

**4. Self-Questioning**

- **Has the rationale for my original choice truly been completely refuted?** No. While DeepSeek emphasizes the need for comparative data, the existing evidence from a large retrospective study showing excellent safety and efficacy outcomes supports the conclusion that VMPA improves access and reduces complications.

- **Is the new choice better than my original choice?** No. Maintaining the "yes" position remains justified given the strength and consistency of the reported outcomes.

- **Explain why you persist with or change your choice:** I persist with the "yes" choice because the substantial positive outcomes reported, including the absence of severe complications and the endorsement of VMPA as the preferred approach, provide strong support. While comparative studies would further strengthen the evidence, the current data sufficiently address the question of whether VMPA itself can improve access and reduce complications.

**5. Final Decision**

**My final choice is: "yes"**
GPT selected: yes

----------------------- Qwen's response -----------------------
Qwen is generating the response...


**1. Position Statement**  
**I disagree with DeepSeek’s viewpoint** and maintain my original position of "yes." While DeepSeek raises valid concerns about study limitations, the abstract’s evidence directly addresses the question’s core inquiry—whether the VMPA itself improves access and reduces complications—without requiring a direct comparison to other approaches.  

**2. Evaluation of Other Models**  
- **GPT’s Analysis**: GPT’s emphasis on the large sample size and favorable outcomes is sound but could have more explicitly tied the anatomical benefits of VMPA (e.g., "direct access and favorable visibility") to reduced complications. However, this does not undermine their conclusion.  
- **DeepSeek’s Analysis**: Overinterprets the question as requiring comparative data to establish "improvement," which is not explicitly stated. The question asks whether VMPA *can* achieve these outcomes, not whether it is *better* than alternatives. Additionally, the claim that "temporary complications" are omitted is misplaced—the abstract specifies "no permanent facial nerve weakness," which is a critical outcome, and does not preclude transient issues from being reported.  

**3. Medical Analysis and Argumentation**  
- **Access and Visibility**: The abstract explicitly states that VMPA provides "direct access and favorable visibility," which are intrinsic anatomical advantages of the approach. These features directly correlate with reduced surgical trauma, shorter operative time, and fewer complications, as surgeons can better navigate the TMJ region.  
- **Complication Data**: The absence of *severe* or *permanent* complications in 606 cases is robust evidence of reduced risks. While DeepSeek critiques the lack of objective metrics (e.g., operative time), the abstract’s outcomes (e.g., zero permanent nerve damage) are clinically definitive and sufficient to answer the question.  
- **Study Design**: Retrospective studies with large cohorts are routinely used to evaluate surgical safety and efficacy, especially when outcomes are binary (e.g., presence/absence of complications). The absence of a control group does not invalidate the conclusion that VMPA *can* reduce complications; it merely limits claims about *superiority*. The question does not require superiority.  
- **Clinical Endorsement**: The abstract’s conclusion—"VMPA can be considered the approach of choice"—reflects clinical consensus, further supporting its merits independent of comparative studies.  

**4. Self-Questioning**  
- **Has the rationale for my original choice been refuted?** No. The abstract’s data and conclusions remain intact, even after addressing DeepSeek’s critiques.  
- **Is the new choice better?** No. Maintaining "yes" is justified because the question does not require comparative evidence, and the VMPA’s demonstrated outcomes align with its ability to improve access and reduce complications.  
- **Why persist?** The question’s phrasing ("Can a Novel Surgical Approach... Improve Access and Reduce Complications?") focuses on the approach’s inherent properties, not its relative superiority. The evidence affirmatively answers this.  

**5. Final Decision**  
**My final choice is: "yes"**
Qwen selected: yes

----------------------- DeepSeek's response -----------------------
DeepSeek is generating the response...


**1. Position Statement**  
**I disagree with their viewpoints because:** Both GPT and Qwen conflate descriptive outcomes with comparative efficacy, misinterpreting the question’s requirement for evidence of *improvement* (which inherently demands comparison) and overlooking critical methodological limitations in the abstract.  

**2. Evaluation of Other Models**  
- **GPT/Qwen’s Key Flaws**:  
  1. **Misdefining "Improvement"**: Both models incorrectly argue that "improvement" does not require comparative data. However, the term *improve* linguistically and scientifically implies a *relative advantage* over prior/alternative methods. The abstract lacks data comparing VMPA to existing approaches (e.g., preauricular), making claims of "improvement" unsupported.  
  2. **Ignoring Outcome Ambiguity**: GPT/Qwen accept "no permanent facial nerve weakness" as proof of reduced complications but ignore the absence of transient complication rates (e.g., temporary nerve injury, hematoma). These omissions undermine the safety profile.  
  3. **Overvaluing Sample Size**: While 606 surgeries are notable, retrospective studies with large samples are still prone to selection bias (e.g., excluding high-risk cases). Neither model addresses how bias might inflate outcomes.  
  4. **Misapplying Clinical Consensus**: Qwen cites the abstract’s endorsement of VMPA as the "approach of choice" as evidence of superiority. However, consensus without comparative data reflects institutional preference, not objective evidence.  

**3. Medical Analysis and Argumentation**  
- **Critical Unaddressed Issues**:  
  1. **Comparative Threshold for Improvement**: To claim VMPA *improves* access, the study must demonstrate metrics like reduced operative time, fewer intraoperative adjustments, or superior surgeon-reported visibility compared to alternatives. The abstract provides none of these.  
  2. **Complication Context**: The absence of severe complications in VMPA does not equate to *reduced* complications unless compared to baseline rates of existing approaches. For example, if traditional methods also have low permanent complication rates, VMPA’s benefit is unproven.  
  3. **Objective Metrics for Access**: "Favorable visibility" is subjective. Quantitative measures (e.g., surgical field exposure scores, endoscopic comparisons) are required to validate this claim.  
  4. **Temporal Bias in Retrospective Design**: Retrospective studies often underreport complications due to inconsistent follow-up. The abstract does not specify follow-up duration or standardize complication tracking.  

- **Strength of Counterarguments**:  
  While GPT/Qwen highlight VMPA’s practical benefits (e.g., esthetic outcomes), these are secondary to the question’s focus on access and complications. The abstract’s positive outcomes are promising but insufficient to conclude *improvement* without comparative or objective data.  

**4. Self-Questioning**  
- **Has the reasoning for my original choice truly been completely refuted?** No. GPT/Qwen’s arguments rely on redefining "improvement" as standalone efficacy rather than comparative advantage, which is inconsistent with evidence-based standards.  
- **Is the new choice better than my original choice?** No. Maintaining "maybe" remains appropriate because the abstract’s data, while supportive of VMPA’s feasibility, do not meet the threshold for answering the question as phrased.  
- **Why persist?** The question explicitly asks whether VMPA *improves* access and *reduces* complications—claims that require comparative evidence absent in the abstract.  

**5. Final Decision**  
**My final choice is: "maybe"**
DeepSeek selected: maybe

-------- Debate round 3 --------

----------------------- GPT's response -----------------------
GPT is generating the response...


**1. Position Statement**

**I agree with Qwen's perspective** and maintain my original position of "yes." While DeepSeek presents important considerations regarding the need for comparative data, the evidence provided in the medical literature abstract sufficiently supports the conclusion that the VMPA can improve access and reduce complications in TMJ surgeries.

**2. Evaluation of Other Models**

- **Qwen's Perspective:** Qwen consistently upholds the "yes" position, aligning with my assessment by emphasizing the substantial sample size (606 TMJ surgeries) and the absence of severe complications. Qwen rightly points out that the question specifically addresses whether VMPA itself can improve access and reduce complications, not necessarily its superiority over other methods. This focus supports the affirmation of the VMPA's benefits based on the provided evidence.

- **DeepSeek's Perspective:** DeepSeek maintains a "maybe" stance, arguing that the retrospective nature of the study and the lack of comparative data with other surgical approaches undermine the conclusiveness of the abstract's claims. DeepSeek asserts that without direct comparisons, it's premature to definitively state that VMPA improves access and reduces complications compared to existing methods.

**3. Medical Analysis and Argumentation**

The abstract under review offers robust evidence supporting the vestibular maxillary paramedian approach (VMPA) for TMJ surgeries:

- **Large Sample Size and Data Reliability:** Conducting 606 TMJ surgeries provides a comprehensive data set, enhancing the reliability of the reported outcomes. A large sample size minimizes the impact of outliers and increases the generalizability of the findings to broader clinical settings.

- **Safety and Complication Profile:** The absence of permanent facial nerve weakness and severe complications in such a considerable number of cases underscores the VMPA's safety. This is a critical factor in surgical approaches, as the risk of nerve damage is a significant concern in TMJ surgeries.

- **Direct Access and Enhanced Visibility:** VMPA's anatomical positioning allows for direct access to the TMJ region with favorable visibility. Improved visibility facilitates surgical precision, potentially reducing operative time and minimizing trauma to surrounding tissues. This directly contributes to a lower incidence of intraoperative and postoperative complications.

- **Esthetic and Functional Outcomes:** Achieving favorable esthetic results reduces patient morbidity related to scarring, while optimal functional outcomes ensure the restoration of TMJ functionality. These factors are paramount in evaluating the success of surgical interventions and patient satisfaction.

While DeepSeek raises valid points regarding the study's retrospective design and absence of comparative data, it's essential to recognize that the primary question pertains to whether VMPA *itself* can improve access and reduce complications. The abstract provides affirmative evidence in this context. Additionally, the endorsement of VMPA as the approach of choice in clinical practice suggests that surgeons have observed tangible benefits, even if not explicitly compared within the study.

Moreover, in surgical research, especially for established anatomical regions like the TMJ, retrospective studies with large sample sizes can offer significant insights. While randomized controlled trials (RCTs) are ideal for determining comparative efficacy, the practical and ethical challenges of conducting RCTs for surgical techniques often necessitate reliance on high-quality retrospective analyses.

**4. Self-Questioning**

- **Has the rationale for my original choice truly been completely refuted?** No. While DeepSeek emphasizes the necessity for comparative data to substantiate claims of improvement, the abstract provides strong evidence that VMPA, as a standalone approach, offers enhanced access and a reduced complication rate. The large sample size and lack of severe complications support the efficacy and safety of VMPA independently.

- **Is the new choice better than my original choice?** No. Maintaining the "yes" position remains justified. The core question focuses on the inherent capabilities of VMPA, not its comparative superiority. The existing evidence adequately addresses this query.

- **Explain why you persist with or change your choice:** I persist with the "yes" choice because the data presented directly supports the benefits of VMPA in improving surgical access and minimizing complications. While comparative studies would provide additional validation, the current evidence sufficiently answers the question at hand.

**5. Final Decision**

**My final choice is: "yes"**
GPT selected: yes

----------------------- Qwen's response -----------------------
Qwen is generating the response...


**1. Position Statement**  
**I disagree with their viewpoints because:** The abstract explicitly supports the VMPA’s anatomical advantages and outcomes, which directly address the question’s focus on whether the approach *can* improve access and reduce complications. DeepSeek’s requirement for comparative data misinterprets the question’s phrasing ("can improve"), while GPT’s analysis, while aligned, underemphasizes the surgical and anatomical rationale for the VMPA’s benefits.  

**2. Evaluation of Other Models**  
- **GPT’s Analysis**:  
  - **Strengths**: Highlights the large sample size (606 cases) and absence of permanent complications, which are critical.  
  - **Gaps**: Fails to explicitly connect the VMPA’s anatomical features (e.g., "direct access") to reduced surgical trauma and complications. This oversight weakens its argument’s depth.  
  - **Misstep**: Overlooks the question’s focus on the VMPA’s *inherent properties* rather than relative superiority.  

- **DeepSeek’s Analysis**:  
  - **Flaws**:  
    1. **Misinterpreting "Improvement"**: The question asks whether the VMPA *can* provide access and reduce complications, not whether it is *better* than other approaches. The abstract’s evidence affirmatively answers this without requiring comparisons.  
    2. **Overemphasis on Transient Complications**: The absence of *permanent* facial nerve weakness (a severe complication) is the most clinically relevant outcome. Transient issues, while important, are not central to the question’s focus on complication reduction.  
    3. **Undermining Retrospective Studies**: Retrospective studies with large cohorts are standard for evaluating surgical safety and efficacy. The absence of a control group does not negate the VMPA’s demonstrated outcomes.  
    4. **Misreading Clinical Consensus**: The abstract’s endorsement of VMPA as the "approach of choice" reflects real-world clinical utility, which is valid evidence of its merits, even without RCTs.  

**3. Medical Analysis and Argumentation**  
- **Anatomical Advantages**:  
  - The VMPA’s "direct access and favorable visibility" inherently reduce surgical complexity. Improved visualization minimizes dissection trauma, nerve injury risks, and operative time—key factors in complication reduction. This is a *mechanistic* advantage of the approach itself, not dependent on comparisons.  
  - For example, in TMJ surgery, accidental facial nerve injury is a major complication. The VMPA’s anatomical pathway likely reduces this risk by providing clearer access to critical structures, as stated in the abstract.  

- **Outcome Validity**:  
  - The absence of permanent facial nerve weakness in 606 cases is robust evidence of reduced complication rates. While transient complications (e.g., temporary swelling) may occur, they are typically self-limiting and do not negate the approach’s safety profile.  
  - The abstract’s focus on "esthetic and functional results" further supports reduced complications, as poor outcomes (e.g., scarring, joint dysfunction) are often linked to surgical trauma.  

- **Study Design Relevance**:  
  - Retrospective studies are routinely used to validate surgical approaches when outcomes are binary (e.g., presence/absence of complications). The large sample size here strengthens the findings’ reliability, even without a control group.  

- **Clinical Relevance**:  
  - The abstract’s conclusion that VMPA is the "approach of choice" reflects surgeon experience and outcomes, which align with the question’s focus on the approach’s potential to improve access and reduce complications.  

**4. Self-Questioning**  
- **Has the reasoning for my original choice truly been completely refuted?**  
  No. The abstract’s anatomical rationale and complication data remain valid. DeepSeek’s critiques (e.g., lack of comparisons) do not invalidate the VMPA’s demonstrated capacity to achieve the outcomes in question.  
- **Is the new choice better than my original choice?**  
  No. Maintaining "yes" is justified because the evidence directly answers whether the VMPA *can* improve access and reduce complications. The question does not require comparative superiority.  
- **Why persist?**  
  The question’s phrasing ("can") focuses on the approach’s inherent properties, not relative efficacy. The VMPA’s anatomical benefits and outcomes (e.g., zero permanent nerve damage) confirm its ability to achieve the stated goals.  

**5. Final Decision**  
**My final choice is: "yes"**
Qwen selected: yes

----------------------- DeepSeek's response -----------------------
DeepSeek is generating the response...


**1. Position Statement**  
**I disagree with their viewpoints because:** Both GPT and Qwen misinterpret the question’s core requirement by conflating standalone efficacy with *improvement* and *reduction*, which inherently demand comparative evidence. Their arguments fail to address the linguistic and methodological necessity of demonstrating relative advantage over existing approaches.  

**2. Evaluation of Other Models**  
- **GPT/Qwen’s Key Flaws**:  
  1. **Misinterpretation of "Improvement"**: Both models incorrectly assert that "improve access" and "reduce complications" do not require comparison to prior methods. However, in medical research, claims of improvement (e.g., "improved access") are only valid when benchmarked against established alternatives. The abstract lacks such comparisons.  
  2. **Overreliance on Mechanistic Rationale**: Qwen argues that VMPA’s anatomical advantages (e.g., "direct access") inherently reduce complications. While plausible, this is speculative without empirical data comparing VMPA to other approaches (e.g., preauricular) to confirm reduced trauma or nerve injury rates.  
  3. **Neglect of Retrospective Study Limitations**: Both models dismiss the inherent biases of retrospective designs (e.g., selection bias, incomplete follow-up). For instance, the absence of transient complications in the abstract could reflect inconsistent reporting rather than true safety superiority.  
  4. **Misapplication of Clinical Consensus**: Citing VMPA as the "approach of choice" reflects institutional preference, not evidence of superiority. Without comparative outcomes, this endorsement is anecdotal.  

**3. Medical Analysis and Argumentation**  
- **Critical Unaddressed Issues**:  
  1. **Linguistic Precision**: The question asks whether VMPA *improves* access and *reduces* complications. These verbs necessitate demonstrating *relative* benefit, not just feasibility. For example, "improved access" requires metrics like reduced operative time or superior visibility scores compared to alternatives, which the abstract omits.  
  2. **Complication Contextualization**: While permanent facial nerve injury is severe, transient complications (e.g., temporary nerve weakness, hematoma) are clinically significant and influence patient recovery. The abstract’s silence on these undermines claims of complication reduction.  
  3. **Objective Surgical Metrics**: "Favorable visibility" is subjective. Quantitative measures (e.g., surgical field exposure scales, intraoperative imaging) are required to validate this claim. Without them, the assertion remains unsubstantiated.  
  4. **Temporal and Selection Biases**: Retrospective studies often exclude high-risk patients or underreport complications due to inconsistent follow-up. The abstract’s lack of standardized complication tracking protocols weakens its safety claims.  

- **Strength of Counterarguments**:  
  While GPT/Qwen highlight VMPA’s anatomical rationale and large sample size, these do not address the question’s demand for *improvement*. A novel approach may achieve good outcomes without surpassing existing methods. For instance, traditional approaches might already have low complication rates (e.g., <1% permanent nerve injury), and VMPA’s 0% rate in 606 cases could reflect comparable—not superior—safety.  

**4. Self-Questioning**  
- **Has the reasoning for my original choice truly been completely refuted?**  
  No. GPT/Qwen’s arguments hinge on redefining "improvement" as standalone efficacy, which ignores the question’s implicit comparative context. The abstract’s data remain insufficient to claim superiority over existing methods.  
- **Is the new choice better than my original choice?**  
  No. Maintaining "maybe" aligns with evidence-based standards: the abstract supports VMPA’s feasibility but lacks the comparative or objective data required to confirm improvement.  
- **Explain why you persist with or change your choice**:  
  The question’s phrasing ("improve," "reduce") necessitates comparative evidence, which the abstract does not provide. Until such data are available, definitive conclusions are premature.  

**5. Final Decision**  
**My final choice is: "maybe"**
DeepSeek selected: maybe

The maximum round has ended, and no complete consensus has been reached. Use majority voting.
Majority voting result: yes

